MTI Named BioAlberta Company of the Year

Metabolomic Technologies was presented with the BioAlberta Company of the Year Award at the 20th Annual BioAlberta Awards Gala. This Award was presented to MTI for excellence and innovation with their flagship product, PolypDx™,  and their strong performance and leadership role in the Alberta business community. MTI was presented the award by Bob Dawson, Senior Manager, Patient Access and Health Policy, from Pfizer Canada.